PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-07-20

Date Title Company
20-Jul-2020 Impact of Covid-19 on Nanoemulsions Market Anticipated to Grow $16.18 Billion by 2027 At a CAGR of 9.5% Wired Release
20-Jul-2020 Impact of Covid-19 on DNA and Gene Chip Market 2020 – Revenue Status & Forecast Report 2027 | CAGR of 11.6% Wired Release
20-Jul-2020 Surgical Mask Market 2020-2027 Growth – CAGR of 7.9% | Market To Reach USD 87.67 Billion By 2027 | Reports And Data Wired Release
20-Jul-2020 Optical Coherence Tomography Market Growth CAGR of 8.4%- Company Overview, Growth and Forecast by 2027 Wired Release
20-Jul-2020 Multiple Sclerosis Therapeutics Market 2020-2027 Global Research, Top Leading player | Biogen Idec, Teva Pharmaceuticals, Etc Wired Release
20-Jul-2020 Pressure Monitoring Market is expected to reach USD 12.01 billion by 2026, at a CAGR 6.4% | Reports and Data Wired Release
20-Jul-2020 Medical Holography Market Growth – CAGR of 27.7% 2020 | Share, Size, Future Demand Forecast By 2027 Wired Release
20-Jul-2020 Hemostat Market 2020-2027 CAGR 6.2% | USD 4.43 billion in 2027 Latest Statistical Report By Reports And Data Wired Release
20-Jul-2020 Hemophilia Market 2020-2027 CAGR of 5.4% Outlook By: Bayer Healthcare, CSL Behring, Novo Nordisk Wired Release
20-Jul-2020 Impact of Covid-19 on Leishmaniasis Treatment Market to Garner $206.5 Mn, Globally, By 2027 at 8.8% CAGR. Wired Release
20-Jul-2020 Disposable Masks Market Emerging Growth Rate 6.4% Top Key Players are Kimberly-Clark Corporation, 3M Company, etc Wired Release
20-Jul-2020 4D Printing in Healthcare market 2020 | To reach USD 39.3 million by the year 2027 | CAGR of 29.8% | Reports And Data Wired Release
20-Jul-2020 Impact of Covid-19 on 3d Cell Culture Market revenue strategy 2020 | 3D Biotek, Lonza Group Ltd., Tecan Trading AG, etc Wired Release
20-Jul-2020 Impact of Covid-19 on Medical Waste Management Market to Reach $18.34 Bn, Globally, by 2027 at 5.3% CAGR. Wired Release
20-Jul-2020 Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization Antengene Corporation